Literature DB >> 21465485

Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells.

Chisato Nakada1, Yoshiyuki Tsukamoto, Keiko Matsuura, Tung Lam Nguyen, Naoki Hijiya, Tomohisa Uchida, Fuminori Sato, Hiromitsu Mimata, Masao Seto, Masatsugu Moriyama.   

Abstract

MiR-210 is significantly up-regulated in clear cell renal cell carcinoma (CCC), but the mechanism and biological consequences of miR-210 up-regulation are poorly understood. Here, we show that miR-210 is highly expressed in renal carcinoma cell lines and that its expression is clearly correlated with accumulation of hypoxia-inducible factor 1α (HIF1α) under normoxia as well as hypoxia, suggesting that miR-210 up-regulation in renal carcinoma cells is most likely due to accumulation of HIF1α. To reveal the effects of miR-210 up-regulation, the miR-210 precursor was transfected into renal carcinoma cells. After transfection, the cells accumulated at the G2/M phase of the cell cycle and their viability was decreased, suggesting that miR-210 overexpression may trigger an event that hinders normal cell division. Immunocytochemistry demonstrated a multipolar spindle accompanied by centrosome amplification in cells overexpressing miR-210. It has been reported that centrosome amplification induces chromosome mis-segregation, finally leading to chromosome instability and aneuploidy. Indeed, the proportion of aneuploid cells (>4n) was increased in miR-210 overexpressed cells. By using the TargetScan and PicTar algorithms, E2F3 was identified as one of the possible targets of miR-210 and was suppressed at the protein level by miR-210. Moreover, the proportion of aneuploid cells was increased in E2F3 siRNA transfected cells. On the basis of these results, we propose that miR-210 up-regulation due to HIF1α accumulation may induce aneuploidy via E2F3 down-regulation at least in part, and may play a role in tumourigenesis and/or progression of CCC.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21465485     DOI: 10.1002/path.2860

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  48 in total

1.  Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity.

Authors:  S Muralimanoharan; C Guo; L Myatt; A Maloyan
Journal:  Int J Obes (Lond)       Date:  2015-04-02       Impact factor: 5.095

Review 2.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

Review 3.  HypoxamiRs and cancer: from biology to targeted therapy.

Authors:  Harriet E Gee; Cristina Ivan; George A Calin; Mircea Ivan
Journal:  Antioxid Redox Signal       Date:  2013-11-22       Impact factor: 8.401

4.  miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Authors:  Xuanyu Chen; Anming Ruan; Xuegang Wang; Weiwei Han; Rong Wang; Ning Lou; Hailong Ruan; Bin Qiu; Hongmei Yang; Xiaoping Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-07       Impact factor: 4.553

5.  miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.

Authors:  S Bhattacharjya; S Nath; J Ghose; G P Maiti; N Biswas; S Bandyopadhyay; C K Panda; N P Bhattacharyya; S Roychoudhury
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

Review 6.  An emerging understanding of long noncoding RNAs in kidney cancer.

Authors:  Shuigen Zhou; Jiandong Wang; Zhengyu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-11       Impact factor: 4.553

7.  MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.

Authors:  Xin Chen; Jia Guo; Ru-Xing Xi; Yu-Wei Chang; Fei-Yang Pan; Xiao-Zhi Zhang
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  MIR-210 modulates mitochondrial respiration in placenta with preeclampsia.

Authors:  S Muralimanoharan; A Maloyan; J Mele; C Guo; L G Myatt; L Myatt
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

Review 9.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

10.  MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Authors:  Martina Redova; Alexandr Poprach; Andrej Besse; Robert Iliev; Jana Nekvindova; Radek Lakomy; Lenka Radova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Ondrej Slaby
Journal:  Tumour Biol       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.